Learn More
Cytokeratin-19 (CK-19) Polyclonal Antibody, Abbomax
Description
Positive control: Human skin, breast carcinoma Cellular location: Cytoplasm.
Specifications
Specifications
| Antigen | Cytokeratin-19 (CK-19) |
| Applications | Immunohistochemistry (Paraffin), Western Blot |
| Classification | Polyclonal |
| Concentration | 0.5 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with proprietary stabilizer and 0.01% sodium azide |
| Gene | KRT19 |
| Gene Accession No. | P08727, P08728, P19001, Q63279 |
| Gene Alias | 40-kDa keratin intermediate filament; AI663979; C K1CS; CK 19; CK19; CK-19; cytokeratin 19; cytokeratin-19; EndoC; K19; K1CS; Ka19; keratin 19; keratin 19, type I; keratin complex 1, acidic, gene 19; keratin, type I cytoskeletal 19; keratin, type I, 40-kd; keratin-19; Krt-1.19; Krt1-19; Krt19; LOC100344434; MGC15366; Type I keratin Ka19 |
| Host Species | Rabbit |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.